nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Critical Appraisal of the Effects of Anesthetics on Immune-system Modulation in Critically Ill Patients With COVID-19
|
Chalkias, Athanasios |
|
|
43 |
3 |
p. e57-e70 |
artikel |
2 |
Advances in the Epidemiology, Diagnosis, and Management of Pediatric Fatty Liver Disease
|
Suri, Anandini |
|
|
43 |
3 |
p. 438-454 |
artikel |
3 |
Antipsychotic Adherence, Resource Use, and Costs Before and After the Initiation of Once-monthly Paliperidone Palmitate Therapy Among Medicaid Beneficiaries With Prior Schizophrenia Relapse
|
Zhdanava, Maryia |
|
|
43 |
3 |
p. 535-548 |
artikel |
4 |
Coffee: More Than Just Your Morning Pick-Me-Up
|
Jhaveri, Ravi |
|
|
43 |
3 |
p. 431-433 |
artikel |
5 |
Editorial Board
|
|
|
|
43 |
3 |
p. ii-iii |
artikel |
6 |
Effect of Pegylated Interferon Plus Tenofovir Combination on Higher Hepatitis B Surface Antigen Loss in Treatment-naive Patients With Hepatitis B e Antigen -positive Chronic Hepatitis B: A Real-world Experience
|
Hu, Chengguang |
|
|
43 |
3 |
p. 572-581.e3 |
artikel |
7 |
Effect of Probiotic, Prebiotic, and Synbiotic Supplementation on Cardiometabolic and Oxidative Stress Parameters in Patients With Chronic Kidney Disease: A Systematic Review and Meta-analysis
|
Bakhtiary, Mahsa |
|
|
43 |
3 |
p. e71-e96 |
artikel |
8 |
Efficacy, Safety, and Tolerability of a Novel Cyclosporine, a Formulation for Dry Eye Disease: A Multicenter Phase II Clinical Study
|
Peng, Wen-yan |
|
|
43 |
3 |
p. 613-628 |
artikel |
9 |
Frequency and Patterns of Prescribing Antihypertensive Agents in Outpatient Kidney Transplant Recipients Among Six Cities in China from 2011 to 2018
|
Hou, Wenjing |
|
|
43 |
3 |
p. 602-612 |
artikel |
10 |
Glycerol Infusion Versus Mannitol for Cerebral Edema: A Systematic Review and Meta-analysis
|
Wang, Jia |
|
|
43 |
3 |
p. 637-649 |
artikel |
11 |
Interindividual Variability in the Pharmacodynamic and Pharmacokinetic Characteristics of Recombinant Human Insulin and Insulin Aspart
|
Li, Ting |
|
|
43 |
3 |
p. 594-601.e1 |
artikel |
12 |
Meta-analysis of the Efficacy and Tolerability of Immune Checkpoint Inhibitors Combined With Chemotherapy in First-line Treatment of Small Cell Lung Cancer
|
Wu, Jiao |
|
|
43 |
3 |
p. 582-593.e2 |
artikel |
13 |
Nonalcoholic Fatty Liver Disease: A Global Perspective
|
Wong, Wei-Kei |
|
|
43 |
3 |
p. 473-499 |
artikel |
14 |
Nonalcoholic Fatty Liver Disease: Epidemiology, Assessments, and Interventions Entering 2021
|
Barritt, A. Sidney |
|
|
43 |
3 |
p. 436-437 |
artikel |
15 |
Noninvasive Evaluation for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
|
Kogachi, Shannon |
|
|
43 |
3 |
p. 455-472 |
artikel |
16 |
Pharmacokinetic Comparability of Risankizumab Formulations in Prefilled Syringe and Auto-injector for Subcutaneous Injection
|
Lon, Hoi-Kei |
|
|
43 |
3 |
p. 629-636 |
artikel |
17 |
Pharmacokinetics and Safety of Extended-release Ranolazine in Korean and White Healthy Subjects
|
Yoo, Hyounggyoon |
|
|
43 |
3 |
p. 526-534.e4 |
artikel |
18 |
Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2
|
Wolfe, Jeannette |
|
|
43 |
3 |
p. 557-571.e1 |
artikel |
19 |
Table of Contents
|
|
|
|
43 |
3 |
p. iv-v |
artikel |
20 |
The COVID-19 mRNA Vaccines and the Pandemic: Do They Represent the Beginning of the End or the End of the Beginning?
|
Jhaveri, Ravi |
|
|
43 |
3 |
p. 549-556 |
artikel |
21 |
Therapy for Nonalcoholic Fatty Liver Disease: Current Options and Future Directions
|
Campbell, Patrick |
|
|
43 |
3 |
p. 500-517 |
artikel |
22 |
The Role of Advanced Practice Providers in the Care of Nonalcoholic Fatty Liver Disease
|
Gajos, Andrea |
|
|
43 |
3 |
p. 518-523 |
artikel |